BioLineRx (BLRX) EPS (Basic) (2013 - 2025)
BioLineRx (BLRX) posted EPS (Basic) of -$0.0 for Q4 2025, up 94.53% on a QoQ basis from -$0.02 in Q3 2025, and down 111.08% year-over-year from $0.01 in Q4 2024.
BioLineRx (BLRX) has 13 years of EPS (Basic) data on file, last reported at -$0.0 in Q4 2025.
- In Q4 2025, EPS (Basic) fell 111.08% year-over-year to -$0.0; the TTM figure through Dec 2025 stood at -$0.0 (up 98.76% YoY), while the FY2025 annual figure was -$0.0, up 69.4% from the prior year.
- EPS (Basic) grew to -$0.0 in Q4 2025, from -$0.02 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.02 in Q2 2023 and bottomed at -$0.1 in Q3 2024.
- A 5-year average of -$0.02 and a median of -$0.01 in 2021 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) surged 202.63% — and 2025, when it plunged 775.08%.
- Year by year, EPS (Basic) stood at -$0.01 in 2021, then surged by 33.28% to -$0.01 in 2022, then slumped by 61.98% to -$0.01 in 2023, then surged by 202.63% to $0.01 in 2024, then tumbled by 111.08% to -$0.0 in 2025.
- The last three EPS (Basic) figures came in at -$0.0 (Q4 2025), -$0.02 (Q3 2025), and -$0.02 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.55 |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | -0.02 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -0.03 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -0.09 |
| Mar 31, 2024 | -0.11 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | -0.02 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | -0.01 |
| Dec 31, 2022 | -0.01 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | -0.01 |
| Dec 31, 2021 | -0.01 |
| Sep 30, 2021 | -0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | -0.02 |
| Dec 31, 2020 | -0.04 |
| Sep 30, 2020 | -0.02 |
| Jun 30, 2020 | -0.03 |
| Mar 31, 2020 | -0.04 |
| Dec 31, 2019 | -0.06 |
| Sep 30, 2019 | -0.03 |
| Jun 30, 2019 | 0.04 |
| Mar 31, 2019 | -0.05 |
| Dec 31, 2018 | -0.05 |
| Sep 30, 2018 | -0.06 |
| Jun 30, 2018 | -0.05 |
| Mar 31, 2018 | -0.06 |
| Dec 31, 2017 | -0.07 |
| Sep 30, 2017 | -0.07 |
| Jun 30, 2017 | -0.05 |
| Mar 31, 2017 | -0.08 |
| Dec 31, 2016 | -0.07 |
| Sep 30, 2016 | -0.08 |
| Jun 30, 2016 | -0.07 |
| Mar 31, 2016 | -0.06 |
| Dec 31, 2015 | -0.08 |
| Sep 30, 2015 | 0.00 |
| Jun 30, 2015 | -0.09 |
| Mar 31, 2015 | -0.10 |
| Dec 31, 2014 | 0.00 |
| Jun 30, 2014 | -0.12 |
| Mar 31, 2014 | -0.01 |
| Dec 31, 2013 | -0.02 |
| Sep 30, 2013 | -0.02 |
| Jun 30, 2013 | -0.02 |
| Mar 31, 2013 | -0.02 |